Neuromodulation devices from companies including Medtronic (NYSE:MDT), Abbott (NYSE:ABT) and SPR Therapeutics are showing promise treating pain. That’s one of the initial takeaways from study results that medical device companies in the neuromodulation space are touting this weekend at NANS 2020 in Las Vegas. NANS is a joint conference of Congress of Neurological Surgeons and the […]
Medtronic touts 3-month clinical trial results using Stimgenics spinal cord stimulation
Medtronic (NYSE:MDT) this week touted results from a three-month clinical trial of the recently acquired Stimgenics Differential Target Multiplexed Spinal Cord Stimulation using Medtronic’s Intellis platform. The large, multicenter randomized controlled trial showed that 80% of patients with chronic back pain that were treated with Differential Target Multiplexed (DTM) reported at least 50% pain relief […]
Medtronic acquires Stimgenics
Medtronic (NYSE:MDT) yesterday said it acquired spinal cord stimulation company Stimgenics for an undisclosed amount. Stimgenics has developed a spinal cord stimulation waveform known as Differential Target Multiplexed Spinal Cord Stimulation. The therapy is delivered through Medtronic’s Intellis platform and is a chronic pain treatment option. “Stimgenics’s research is deeply rooted in clinical science that began […]
BioNess wins CE Mark for StimRouter neuromod system
BioNess announced today that it won CE Mark approval for its StimRouter neuromodulation system indicated for the treatment of fecal incontinence. The StimRouter system previously won approval for treating chronic pain and overactive bladder. The small implantable system targets the tibial nerve near the ankle. Patients undergoing the StimRouter implant procedure receive one incision as […]
CES 2020: Medical technologies you need to know
The mobile health devices and wearables trend is seemingly accelerating this year, with 546 digital health and 635 wearable devices being touted at the annual CES show in Las Vegas. Digital health devices and wearables on display are up from the 505 and 620 devices, respectively, presented at CES 2019. Health and medical devices being […]
NeuroMetrix CEO cuts his salary to $1
Dr. Shai N. Gozani, CEO of pain-treating TENS device company NeuroMetrix (NSDQ:NURO), is cutting his annual salary to $1 from a previous $422,200 — accepting a stock option to purchase 100,000 shares instead. The 2020 executive compensation package, approved Dec. 29 by the company board’s compensation committee, also cuts salaries in return for stock options for […]
Medtronic pain pump recall deemed Class I
The FDA has classified the recall of Medtronic’s (NYSE:MDT) SynchroMed II implantable drug pumps as Class I, the most serious type of recall. The company announced the voluntary recall in October, saying that it had received complaints about the pumps’ motors stalling permanently. Permanent motor stall could prevent the infusion of drugs to the patient, […]
SPR Therapeutics announces 1000th placement of nerve stimulation device
SPR Therapeutics announced the 1000th commercial placement of its Sprint peripheral nerve stimulation (PNS) system for treating pain. Dr. Henry Vucetic of University Hospitals Case Medical Center (Cleveland) performed the 1000th procedure, treating a patient with shoulder pain due to osteoarthritis. The Sprint PNS system is the only percutaneous PNS device cleared by the FDA […]
Micro-Leads collects $10m for neuromod therapy
Clinical neurostimulation startup Micro-Leads announced that it was awarded $10 million by a National Institutes of Health initiative for funding therapy development. Somerville, Mass.-based Micro-Leads develops the HD64 implantable therapy system for spinal cord stimulation. The device is designed to treat lower back pain and focal pains of the trunk and extremities by delivering electrical […]
Stimwave Technologies stops commercialization of products in Australia
Stimwave Technologies announced today that it is stopping the commercialization of its product lines in Australia until its entire product family can be legally marketed in the country. The neuromodulation therapy alternative developer’s products include the Freedom SCS system and the StimQ PNS system, which are designed to reduce the risks associated with implantable pulse […]
This injectable electrode could lower the cost of neuromodulation therapy
Researchers at the University of Wisconsin-Madison have developed an injectable, flexible electrode that could replace rigid nerve-stimulating implants and reduce the cost of neuromodulation therapy. The researchers’s new type of electrode can be injected as a liquid and cure within the body. Traditional neuromodulation treatments require surgically implanted devices that can cost up to six […]
- 1
- 2
- 3
- …
- 34
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube